Publications Office of the EU
Spain-L'Hospitalet de Llobregat: Reagents and contrast media - EU tenders
DisplayCustomHeader
MyPortal
Language Selector
English
BasketSummary
Procurement Detail Actions Portlet

Utilities

Procurement Detail Actions Portlet
OP Portal - Procurement - Details

Spain-L'Hospitalet de Llobregat: Reagents and contrast media

Overview
  • Awarded
    26/03/2021
  • Today
    06/08/2026
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
Consorci Sanitari Integral
Place of performance
NUTS code: ES España
Location of buyer
NUTS code: ES511 Barcelona
Business sector (Main CPV)
33696000 Reagents and contrast media
Total estimated contract value (excluding VAT)
753,522.00
Total final contract value (excluding VAT)
753,522.00 EUR
Procedure details
Tender reference number
CB CSI CSC F 4/17 BIS
Description

Adjudicación del contrato basado del Acuerdo Marco del Suministro de Contrastes

Submission Method
Not available
Tenders may be submitted
Not applicable
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
The procurement involves the establishment of a framework agreement
Conditions for opening tenders (date)
Not available
Place of performance
ES España
CPV code

33696000 - Reagents and contrast media

Award method
Lowest price
Estimated value
753,522.00
Final contracted value
753,522.00 EUR
Award of contract
Official name: LABORATORIOS FARMACÉUTICOS ROVI, S.A.
Postal address:
Town: Madrid
Postal code:
Country: ESP
Documents
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.